February 26, 2021
By Jeffrey M. Jacobstein; Sara A. Leiman, Ph.D.; Oulu (Lulu) Wang, Ph.D.
The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance. The Life Sciences Podcasts Series looks at some of the hottest topics in the Life Sciences industry. In this podcast, Finnegan attorneys Jeff Jacobstein, Sara Leiman, and Lulu Wang discuss the importance of clinical trial-based patent applications and strategic considerations to keep in mind for these types of patents.
Articles
This Article Was Written Entirely by AI — Welcome to Synthetic Patent Litigation
July/August 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.